Treatment of bronchiolitis in infants and childrentext editorEmerging Infectious Diseases
Children who have undiagnosed asthma for several years are most susceptible. Contact the doctor the moment you observe symptoms. It is better to nip an infection in the bud rather than prolong it and face problems later.Also Read: Bronchiolitis in Infants...
The European Union has approved a preventative treatment for the very common virus that causes the chest infection bronchiolitis in infants, the companies that developed the drug said Friday. The greenlight from the European Commission comes as several countries have seen surging cases of bronchiolitis ...
Nebulised deoxyribonuclease for viral bronchiolitis in children younger than 24 months. Background Bronchiolitis is one of the most common respiratory problems in the first year of life. The sputum of infants with bronchiolitis has increased d... A Enriquez,IW Chu,C Mellis,... - 《Cochrane Data...
The effect of inhaled nebulised racemic adrenaline upon symptoms of acute bronchiolitis was investigated in 29 infants and toddlers aged 2-17.5 months by transcutaneous oxygen tension (TcPO2), oxygen saturation, transcutaneous carbon dioxide tension (TcPCO2), and clinical evaluation in a double blind ...
A study from the Centers for Disease Control and Prevention (CDC) showed that nirsevimab prevented infants from being hospitalized with RSV, which causes bronchiolitis, in nine out of ten cases, the agency said. The CDC said it recommends the antibody drug for infants under eight months whose...
Objective: The aim of this review was to address advances in management and treatment of acute viral bronchiolitis in infants. Sources: A systematic review search was made including all articles published in English between 2010 and 2017, and available in the electronic databases PubMed and ...
Aged patients with chronic obstructive pulmonary disease tolerated the treatment with little difficulty, and a group of infants and children with RSV disease recovered promptly with no evidence of intolerance to the treatment. This modification of dosage offers increased accessibility for patient care, ...
As bronchiolitis continues to be the most common cause of hospitalization in infants 12 months and younger, we continue to search for the remedy that will improve symptoms, shorten hospitalization and prevent worsening of disease.[34] Although initially promising, large randomized controlled trials show...
There is no effective therapy for RSV bronchiolitis. To investigate the efficacy of clarithromycin in the treatment of RSV bronchiolitis, we conducted a randomized, double-blind, placebo controlled trial comparing clarithromycin with placebo in 21 infants with a diagnosis of RSV bronchiolitis. The ...